Venlafaxine and mirtazapine treatment lowers serum concentrations of dehydroepiandrosterone-sulfate in depressed patients remitting during the course of treatment

Journal of Psychiatric Research - Tập 44 - Trang 556-560 - 2010
Georgios Paslakis1, Peter Luppa2, Maria Gilles1, Daniel Kopf1, Bettina Hamann-Weber1, Florian Lederbogen1, Michael Deuschle1
1Central Institute of Mental Health, Dept. of Psychiatry and Psychotherapy, J5, 68159 Mannheim, Germany
2Institute of Clinical Chemistry and Pathobiochemistry, Technical University, Munich, Germany

Tài liệu tham khảo

Barrett-Connor, 1999, Endogenous levels of dehydroepiandrosterone sulfate, but not other sex hormones, are associated with depressed mood in older women: the Rancho Bernardo Study, Journal of the American Geriatrics Society, 47, 685, 10.1111/j.1532-5415.1999.tb01590.x Baulieu, 1996, Dehydroepiandrosterone and dehydroepiandrosterone sulfate as neuroactive neurosteroids, Journal of Endocrinology, 150, S221 Berr, 1996, Relationships of dehydroepiandrosterone sulfate in the elderly with functional, psychological, and mental status, and short-term mortality: a French community-based study, Proceedings of the National Academy of Sciences of the United States of America, 93, 13410, 10.1073/pnas.93.23.13410 Bloch, 1999, Dehydroepiandrosterone treatment of midlife dysthymia, Biological Psychiatry, 45, 1533, 10.1016/S0006-3223(99)00066-9 Bovenberg, 2005, Dehydroepiandrosterone administration in humans: evidence based?, The Netherlands Journal of Medicine, 63, 300 Coenen, 1996, Changes in androgens during treatment with four low-dose contraceptives, Contraception, 53, 171, 10.1016/0010-7824(96)00006-6 Deuschle, 2003, Antidepressive treatment with amitriptyline and paroxetine: effects on saliva cortisol concentrations, Journal of Clinical Psychopharmacology, 23, 201, 10.1097/00004714-200304000-00014 Deuschle, 2004, Antidepressant treatment and dehydroepiandrosterone sulfate: different effects of amitriptyline and paroxetine, Neuropsychobiology, 50, 252, 10.1159/000079980 Fabian, 2001, Endogenous concentrations of DHEA and DHEA-S decrease with remission of depression in older adults, Biological Psychiatry, 50, 767, 10.1016/S0006-3223(01)01198-2 Gallagher, 2002, Cortisol/DHEA ratios in depression, Neuropsychopharmacology, 26, 410, 10.1016/S0893-133X(01)00362-1 Greco, 2007, The effects of oral contraceptives on androgen levels and their relevance to premenstrual mood and sexual interest: a comparison of two triphasic formulations containing norgestimate and either 35 or 25 μg of ethinyl estradiol, Contraception, 76, 8, 10.1016/j.contraception.2007.04.002 Grottoli, 2002, Alprazolam, a benzodiazepine, does not modify the ACTH and cortisol response to hCRH and AVP, but blunts the cortisol response to ACTH in humans, Journal of Endocrinological Investigation, 25, 420, 10.1007/BF03344031 Hansen, 1982, Dehydroepiandrosterone and affective disorders, American Journal of Psychiatry, 139, 386, 10.1176/ajp.139.3.386a Herbert, 1998, Neurosteroids, brain damage, and mental illness, Experimental Gerontology, 33, 713, 10.1016/S0531-5565(98)00039-4 Heuser, 1998, Increased diurnal plasma concentrations of dehydroepiandrosterone in depressed patients, Journal of Clinical Endocrinology & Metabolism, 83, 3130, 10.1210/jc.83.9.3130 Hsiao, 2006, Difference in pre- and post-treatment plasma DHEA levels were significantly and positively correlated with difference in pre- and post-treatment Hamilton depression scores following successful therapy for major depression, Psychoneuroendocrinology, 31, 839, 10.1016/j.psyneuen.2006.03.008 Hsiao, 2006, Positive correlation between anxiety severity and plasma levels of dehydroepiandrosterone sulfate in medication-free patients experiencing a major episode of depression, Psychiatry and Clinical Neurosciences, 60, 746, 10.1111/j.1440-1819.2006.01590.x Kroboth, 1999, Alprazolam increases dehydroepiandrosterone concentrations, Journal of Clinical Psychopharmacology, 19, 114, 10.1097/00004714-199904000-00005 Maayan, 2000, Basal plasma dehydroepiandrosterone sulfate level: a possible predictor for response to electroconvulsive therapy in depressed psychotic inpatients, Biological Psychiatry, 48, 693, 10.1016/S0006-3223(00)00848-9 Majewska, 1990, The neurosteroid dehydroepiandrosterone sulfate is an allosteric antagonist of the GABAA receptor, Brain Research, 526, 143, 10.1016/0006-8993(90)90261-9 Markopoulou, 2009, The ratio of cortisol/DHEA in treatment resistant depression, Psychoneuroendocrinology, 34, 19, 10.1016/j.psyneuen.2008.08.004 Maurice, 1996, Modulation by neurosteroids of the in vivo (+)-[3H]SKF-10, 047 binding to sigma 1 receptors in the mouse forebrain, Journal of Neuroscience Research, 46, 734, 10.1002/(SICI)1097-4547(19961215)46:6<734::AID-JNR10>3.0.CO;2-U Michael, 2000, Altered salivary dehydroepiandrosterone levels in major depression in adults, Biological Psychiatry, 48, 989, 10.1016/S0006-3223(00)00955-0 Morrison, 2001, DHEA-S levels and depressive symptoms in a cohort of African American and Caucasian women in the late reproductive years, Biological Psychiatry, 50, 705, 10.1016/S0006-3223(01)01169-6 Muller, 2006, Mice with mutations in the HPA-system as models for symptoms of depression, Biological Psychiatry, 59, 1104, 10.1016/j.biopsych.2006.02.008 Rabkin, 2006, Placebo-controlled trial of dehydroepiandrosterone (DHEA) for treatment of nonmajor depression in patients with HIV/AIDS, American Journal of Psychiatry, 163, 59, 10.1176/appi.ajp.163.1.59 Romeo, 1998, Effects of antidepressant treatment on neuroactive steroids in major depression, American Journal of Psychiatry, 155, 910, 10.1176/ajp.155.7.910 Rosenfeld, 1975, 24-Hour secretory pattern of dehydroisoandrosterone and dehydroisoandrosterone sulfate, Journal of Clinical Endocrinology & Metabolism, 40, 850, 10.1210/jcem-40-5-850 Scharnholz B, Hamann B, Lederbogen F, Schilling C, Gilles M, Onken V, et al. Antidepressive treatment with mirtazapine, but not venlafaxine lowers cortisol concentrations in saliva: a randomised-open trial. Psychiatry Research 2009, in press. Schmidt, 2005, Dehydroepiandrosterone monotherapy in midlife-onset major and minor depression, Archives of General Psychiatry, 62, 154, 10.1001/archpsyc.62.2.154 Schüle, 2009, Effects of mirtazapine on dehydroepiandrosterone-sulfate and cortisol plasma concentrations in depressed patients, Journal of Psychiatric Research, 43, 538, 10.1016/j.jpsychires.2008.07.003 Schüle, 2003, Influence of sleep deprivation on neuroactive steroids in major depression, Neuropsychopharmacology, 28, 577, 10.1038/sj.npp.1300084 Scott, 1999, Differences in adrenal steroid profile in chronic fatigue syndrome, in depression and in health, Journal of Affective Disorders, 54, 129, 10.1016/S0165-0327(98)00169-4 T’Sjoen, 2005, Sex steroid level, androgen receptor polymorphism, and depressive symptoms in healthy elderly men, Journal of the American Geriatrics Society, 53, 636, 10.1111/j.1532-5415.2005.53212.x Takebayashi, 1998, Plasma dehydroepiandrosterone sulfate in unipolar major depression. Short communication, Journal of Neural Transmission, 105, 537, 10.1007/s007020050077 Thomas, 1994, Serum dehydroepiandrosterone sulfate levels as an individual marker, Journal of Clinical Endocrinology & Metabolism, 79, 1273, 10.1210/jc.79.5.1273 Tollefson, 1990, 24 hour urinary dehydroepiandrosterone sulfate in unipolar depression treated with cognitive and/or pharmacotherapy, Annals of Clinical Psychiatry, 2, 39, 10.3109/10401239009150005 van Broekhoven, 2003, Neurosteroids in depression: a review, Psychopharmacology (Berl), 165, 97, 10.1007/s00213-002-1257-1 Weber, 2000, Testosterone, androstenedione and dihydrotestosterone concentrations are elevated in female patients with major depression, Psychoneuroendocrinology, 25, 765, 10.1016/S0306-4530(00)00023-8 Wolf, 1997, A single administration of dehydroepiandrosterone does not enhance memory performance in young healthy adults, but immediately reduces cortisol levels, Biological Psychiatry, 42, 845, 10.1016/S0006-3223(97)00323-5 Wolkowitz, 1994, Prospective controlled studies of the behavioral and biological effects of exogenous corticosteroids, Psychoneuroendocrinology, 19, 233, 10.1016/0306-4530(94)90064-7 Wolkowitz, 1999, Double-blind treatment of major depression with dehydroepiandrosterone, American Journal of Psychiatry, 156, 646, 10.1176/ajp.156.4.646 Wolkowitz, 1997, Dehydroepiandrosterone (DHEA) treatment of depression, Biological Psychiatry, 41, 311, 10.1016/S0006-3223(96)00043-1 Yaffe, 1998, Neuropsychiatric function and dehydroepiandrosterone sulfate in elderly women: a prospective study, Biological Psychiatry, 43, 694, 10.1016/S0006-3223(97)00303-X Young, 2002, Elevation of the cortisol-dehydroepiandrosterone ratio in drug-free depressed patients, American Journal of Psychiatry, 159, 1237, 10.1176/appi.ajp.159.7.1237 Zobel, 2001, Cortisol response in the combined dexamethasone/CRH test as predictor of relapse in patients with remitted depression. A prospective study, Journal of Psychiatric Research, 35, 83, 10.1016/S0022-3956(01)00013-9